Sign In
Bristol-Myers Squibb Company (BMY)
SHARE
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
James M. Cornelius, CEO/Director/Chairman of the Board
345 Park Avenue
New York, NY 10154
US
Map it 
Phone: (212) 546-4000
Fax: (212) 546-4020
Latest news from Portfolio
-
Drug Executive IndictedApr 24 2008
-
Not-So-Happy Holidays for Bristol-Myers WorkersDec 05 2007
-
A Big Boost for BristolJun 19 2007
-
A New Day for Bristol-Myers?Apr 26 2007
Overview
The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other health care related products.
Portfolio Articles
-
Drug Executive Indicted
The Plavix affair results in a criminal charge.Apr 24 2008 -
Not-So-Happy Holidays for Bristol-Myers Workers
Company slashes workforce, raises forecast and dividend.Dec 05 2007 -
A Big Boost for Bristol
After
Jun 19 2007 -
A New Day for Bristol-Myers?
After months of takeover speculation, Bristol-Myers appoints a new C.E.O. and strikes a partnership with Pfizer.Apr 26 2007
Portfolio Blogs
-
Cash: The Winners and Losers
Mar 23 2009
-
A Bitter Pill for Bristol-Myers to Swallow
Oct 01 2007
Press Releases
-
New Online Resource Launches For Patients With Chronic Myeloid Leukemia Jul-06-2009, 09:00AM EDT
-
ONGLYZA(TM) (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes Jun-25-2009, 03:59PM EDT
-
Technical Trade Alerts For Healthcare Stocks: Issued By BestDamnPennyStocks.com Jun-18-2009, 01:32PM EDT
-
ORENCIA(R) (abatacept) DEMONSTRATES CONSISTENT SAFETY AND EFFECTIVENESS OVER 7 YEARS Jun-12-2009, 03:00AM EDT
-
Diversified Search Odgers Berndtson Opens Atlanta Office Jun-10-2009, 04:06PM EDT
News From Around the Web
News
-
Early Glance: Pharmaceuticals companies (Businessweek)Jul 09 2009
-
Pharmaceuticals companies shares mixed at 10 a.m. (Canadian Business Online)Jul 08 2009
-
New Online Resource Launches For Patients With Chronic Myeloid Leukemia (Medical News Today)Jul 08 2009
-
Pharmaceuticals companies shares mixed at the close of trading (Canadian Business Online)Jul 07 2009
-
Jul 07 2009
-
Jul 07 2009
-
Bristol-Myers Squibb cutting 25 jobs (NBC 3 Syracuse (WSTM))Jul 06 2009
-
Jul 06 2009
-
Final Glance: Pharmaceuticals companies (Boston Globe)Jul 03 2009
Blogs
-
Bad Omen for Stocks?: Coming Corporate ‘Carve Outs’ (WSJ.com: MarketBeat Blog)Jul 09 2009
-
Onglyza - prepare for launch (PharmaGossip)Jul 09 2009
-
Hey, What's Up Doc? (CNBC: Pharmas Market with Mike Huckman)Jul 06 2009
Employees
Number of Employees: 42,000
Revenue per Employee: $434,116
Financials
Quarterly
Annual
| Income Statement | 01/2009 | 10/2008 | 07/2008 | 04/2008 |
|---|---|---|---|---|
| Sales | 1.52 Bil. | 1.45 Bil. | 1.47 Bil. | 1.41 Bil. |
| Gross Operating Profit | 3.73 Bil. | 3.8 Bil. | 3.74 Bil. | 3.78 Bil. |
| Operating Income before D & A (EBITDA) | 850 Mil. | 1.4 Bil. | 1.32 Bil. | 1.43 Bil. |
| Total Income Before Interest Expenses (EBIT) | 1.89 Bil. | 1.24 Bil. | 1.3 Bil. | 1.36 Bil. |
| Total Net Income | 1.24 Bil. | 2.58 Bil. | 764 Mil. | 661 Mil. |
| Basic EPS, Total | 0.63 | 1.3 | 0.39 | 0.33 |
| Diluted EPS, Total | 0.63 | 1.29 | 0.38 | 0.33 |
| BALANCE STATEMENT | 01/2009 | 10/2008 | 07/2008 | 04/2008 |
|---|---|---|---|---|
| Cash and Equivalents | NA | 7.17 Bil. | 4.05 Bil. | 2.44 Bil. |
| Total Assets | NA | 14.78 Bil. | 12.84 Bil. | 10.58 Bil. |
| Total Liabilities | NA | 6.95 Bil. | 8.64 Bil. | 8.44 Bil. |
| Total Capitalization | NA | 19.06 Bil. | 16.8 Bil. | 15.22 Bil. |
| Cash Flow | 01/2009 | 10/2008 | 07/2008 | 04/2008 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | 3.34 Bil. | 1.92 Bil. | 779 Mil. |
| Net Cash From Investing Activities | NA | 4 Bil. | 46 Mil. | 572 Mil. |
| Net Cash From Financing Activities | NA | -1.98 Bil. | 254 Mil. | -734 Mil. |
| Net Change in Cash & Cash Equivalents | NA | 5.37 Bil. | 2.25 Bil. | 642 Mil. |
| Income Statement | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|
| Sales | 6.4 Bil. | 6.22 Bil. | 5.03 Bil. | 5 Bil. |
| Gross Operating Profit | 14.2 Bil. | 13.13 Bil. | 12.88 Bil. | 14.21 Bil. |
| Operating Income before D & A (EBITDA) | 4.27 Bil. | 3.53 Bil. | 3.55 Bil. | 4.88 Bil. |
| Total Income Before Interest Expenses (EBIT) | 5.47 Bil. | 3.43 Bil. | 3.13 Bil. | 4.86 Bil. |
| Total Net Income | 5.25 Bil. | 2.14 Bil. | 1.58 Bil. | 3 Bil. |
| Basic EPS, Total | 2.65 | 1.1 | 0.81 | 1.53 |
| Diluted EPS, Total | 2.63 | 1.09 | 0.81 | 1.52 |
| BALANCE STATEMENT | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|
| Cash and Equivalents | NA | NA | 2.02 Bil. | 3.05 Bil. |
| Total Assets | NA | NA | 10.3 Bil. | 12.28 Bil. |
| Total Liabilities | NA | NA | 6.5 Bil. | 6.89 Bil. |
| Total Capitalization | NA | NA | 17.24 Bil. | 19.57 Bil. |
| Cash Flow | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | NA | 2.08 Bil. | 1.84 Bil. |
| Net Cash From Investing Activities | NA | NA | 206 Mil. | 1.19 Bil. |
| Net Cash From Financing Activities | NA | NA | -3.35 Bil. | -3.64 Bil. |
| Net Change in Cash & Cash Equivalents | NA | NA | -1.03 Bil. | -630 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
54.72 Bil.
57.56 Bil.
30.81 Bil.
63.75 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read